Acute Myeloid Leukemia
publications
ROMER-SEIBERT AND MEYER CURRENT OPINION IN HEMATOLOGY 2021
Genetic heterogeneity and clonal evolution in acute myeloid leukemia
MEYER ET AL. JOURNAL of EXPERIMENTAL MEDICINE 2018
miR-196b target screen reveals mechanisms maintaining leukemia stemness with therapeutic potential
Skp2 inhibitor treatment for AML.
sara meyer
From EMT to HSC to AML: ZEB2 is a cell fate switch
Inside Blood commentary on complimentary studies by J. Li et al and H. Li et al.
meyer et aL. cancer discovery 2016
DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia
The first mouse model of DNMT3A/FLT3-mutant AML.
Our Team
Sara meyer, PhD
Assistant Professor of Cancer Biology and Medical Oncology
Sidney Kimmel Cancer Center, Thomas Jefferson University
Postdoc Fellowship, Cincinnati Children's Hospital Medical Center
PhD, University of Cincinnati
melanie goetz
PhD Candidate, Biochemistry & Molecular Pharmacology Program
BS, Muhlenberg College
Melanie is studying the therapeutic utility of epigenetic drugs in AML and the clonal heterogeneity of epigenetic-mutant AML.
Melanie.Goetz@students.jefferson.edu
MICHAEL LAWLER, MS
PhD Candidate, Genetics Genomics & Cancer Biology Program
MS, Thomas Jefferson University
BS, DeSales University
Mike is studying the roles of innate immune signaling pathways in AML.
Michael.Lawler@students.jefferson.edu
Olivia Mowery
Research Technician
BS, La Salle University
Olivia is a research technician.
Olivia.Mowery@jefferson.edu
Past lab members
Sarah Broskin, MS, Research Technician (Johnson & Johnson)
Isabel Jacob, Undergradate student, Jefferson Honors Institute (Lake Erie College of Osteopathic Medicine Early Acceptance Program)
Amanda Versace, Research Assistant (University of Pennsylvania)
Holly Gamlen, BS, Drexel Master’s student (SUNY Upstate Medical University)
Jennifer Romer-Seibert, Postdoc Fellow (Analytical Biological Services)
News
Congratulations to Mike! Awarded a Travel Scholarship and platform talk at the Keystone Hematopoiesis Meeting!
January 2019
Congratulations to Jen! Awarded NCI T32 funding support!!!
December 2019
SKCC awards collaborative pilot project grant to the Meyer and Hou Labs!
March 2019
Congratulations to the Meyer lab and thank you to our funders for their support!!!!
NCI R01 awarded and converted to the NCI R37 MERIT Award!
Concern Foundation awarded a Conquer Cancer Now grant!
July 2018
July 2018
NERD NITE PHILLY
Sara speaking at Nerd Nite co-sponsored by the American Cancer Society.
May 2017
ACS CAN in action!
Sara went to Capitol Hill for the American Cancer Society's Cancer Lobby Day with fellow volunteers and cancer survivors to tell Congress investing in cancer research and supporting cancer care legislation should be a National priority.
September 2017
Funding
NCI
R37 MERIT Award
We thank the NIH/NCI for their investment in New Early Stage Investigators and for supporting our research!
Concern Foundation
Conquer Cancer Now Award
We thank the Concern Foundation for their generous support of Young Investigator labs and support of our research!
American Cancer Society
Institutional Research Grant
Thank you to ACS for continuous support of our cancer research!
Thomas Jefferson university
Sidney kimmel cancer center
center city, philadelphia
The NCI-designated Sidney Kimmel Cancer Center at Thomas Jefferson University and Jefferson Health is located in the heart of Center City Philadelphia, PA.
TJU and skMc colleges
TJU's Center City campus offers a variety of educational opportunities in the Sidney Kimmel Medical College, Jefferson College of Life Sciences, Health Professions, Nursing, Pharmacy, and Population Health.
home of the eagles
Philadelphia's Eagles NFL Champions 2018, crowds flooded Center City to celebrate the victory.
Contact
Sara Meyer
233 S. 10th St.
Bluemle Life Sciences Building
Sara.Meyer@jefferson.edu